NYSE - Nasdaq Real Time Price USD

Cardinal Health, Inc. (CAH)

Compare
112.72 +0.52 (+0.46%)
At close: August 30 at 4:00 PM EDT
Loading Chart for CAH
DELL
  • Previous Close 112.20
  • Open 112.23
  • Bid 92.00 x 1100
  • Ask 113.16 x 900
  • Day's Range 111.88 - 113.13
  • 52 Week Range 85.82 - 116.04
  • Volume 1,836,612
  • Avg. Volume 1,938,519
  • Market Cap (intraday) 27.486B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 32.67
  • EPS (TTM) 3.45
  • Earnings Date Nov 1, 2024 - Nov 5, 2024
  • Forward Dividend & Yield 2.02 (1.79%)
  • Ex-Dividend Date Oct 1, 2024
  • 1y Target Est 117.08

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

www.cardinalhealth.com

47,922

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CAH

View More

Research Reports: CAH

View More

Performance Overview: CAH

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CAH
12.91%
S&P 500
18.42%

1-Year Return

CAH
28.07%
S&P 500
25.59%

3-Year Return

CAH
136.71%
S&P 500
25.26%

5-Year Return

CAH
212.31%
S&P 500
93.14%

Compare To: CAH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CAH

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    27.49B

  • Enterprise Value

    27.45B

  • Trailing P/E

    32.67

  • Forward P/E

    14.88

  • PEG Ratio (5yr expected)

    0.97

  • Price/Sales (ttm)

    0.12

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.12

  • Enterprise Value/EBITDA

    13.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.38%

  • Return on Assets (ttm)

    3.03%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    226.83B

  • Net Income Avi to Common (ttm)

    852M

  • Diluted EPS (ttm)

    3.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.33B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    3.96B

Research Analysis: CAH

View More

Company Insights: CAH

People Also Watch